Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability

Philip J M BrouwerMarit J van Gils


The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has had a large impact on global health, travel, and economy. Therefore, preventative and therapeutic measures are urgently needed. Here, we isolated monoclonal antibodies from three convalescent coronavirus disease 2019 (COVID-19) patients using a SARS-CoV-2 stabilized prefusion spike protein. These antibodies had low levels of somatic hypermutation and showed a strong enrichment in VH1-69, VH3-30-3, and VH1-24 gene usage. A subset of the antibodies was able to potently inhibit authentic SARS-CoV-2 infection at a concentration as low as 0.007 micrograms per milliliter. Competition and electron microscopy studies illustrate that the SARS-CoV-2 spike protein contains multiple distinct antigenic sites, including several receptor-binding domain (RBD) epitopes as well as non-RBD epitopes. In addition to providing guidance for vaccine design, the antibodies described here are promising candidates for COVID-19 treatment and prevention.


Feb 26, 2000·Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners·T Sandritter
Jul 21, 2004·Journal of Computational Chemistry·Eric F PettersenThomas E Ferrin
Mar 6, 2009·Journal of Structural Biology·Gabriel C LanderBridget Carragher
Apr 14, 2009·Nature Methods·Daniel G GibsonHamilton O Smith
Sep 25, 2012·Journal of Structural Biology·Sjors H W Scheres
Dec 24, 2013·Current Topics in Microbiology and Immunology·Jason S McLellanMark E Peeples
Apr 30, 2014·Proceedings of the National Academy of Sciences of the United States of America·Xian-Chun TangWayne A Marasco
Jun 12, 2014·Frontiers in Immunology·Lei Yu, Yongjun Guan
Nov 26, 2014·Proceedings of the National Academy of Sciences of the United States of America·Devin SokDennis R Burton
Jan 7, 2016·The New England Journal of Medicine·Johan van GriensvenUNKNOWN Ebola-Tx Consortium
Sep 1, 2016·Annual Review of Virology·Fang Li
Nov 15, 2016·Nature Microbiology·Marit J van GilsRogier W Sanders
Aug 16, 2017·Proceedings of the National Academy of Sciences of the United States of America·Jesper PallesenJason S McLellan
Oct 12, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nithya J GogtayPrasad S Kulkarni
Jun 4, 2018·The Journal of Infectious Diseases·Kristen E PascalChristos A Kyratsous
Aug 20, 2019·Current Opinion in Virology·Marloes GrobbenMarit J van Gils
Sep 26, 2019·Cell Reports·Nianshuang WangJason S McLellan
Nov 28, 2019·The New England Journal of Medicine·Sabue MulanguUNKNOWN PALM Consortium Study Team
Feb 23, 2020·Science·Daniel WrappJason S McLellan
Feb 23, 2020·The Lancet Infectious Diseases·Ensheng DongLauren Gardner
Mar 11, 2020·Cell·Alexandra C WallsDavid Veesler
Mar 29, 2020·JAMA : the Journal of the American Medical Association·Chenguang ShenLei Liu
Mar 30, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Juanjuan ZhaoZheng Zhang
Apr 1, 2020·Nature·Jian ShangFang Li
Apr 7, 2020·Trends in Immunology·Shibo JiangLanying Du
Apr 9, 2020·Emerging Infectious Diseases·Nisreen M A OkbaBart L Haagmans
May 6, 2020·Nature Communications·Chunyan WangBerend-Jan Bosch

❮ Previous
Next ❯


Jul 6, 2020·Nature·Gary R Whittaker, Susan Daniel
Sep 18, 2020·Expert Opinion on Therapeutic Targets·Shibo JiangLanying Du
Sep 4, 2020·Signal Transduction and Targeted Therapy·Xiangyu ChenLilin Ye
Jul 24, 2020·Nature Structural & Molecular Biology·Rory HendersonPriyamvada Acharya
Aug 14, 2020·Nature·Mark J MulliganKathrin U Jansen
Jul 15, 2020·Science·Meng YuanIan A Wilson
Aug 29, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Tyler E MillerJochen K Lennerz
Sep 24, 2020·Signal Transduction and Targeted Therapy·Fei YuShibo Jiang
Jul 22, 2020·The Journal of Experimental Medicine·Fabian SchmidtPaul D Bieniasz
Aug 21, 2020·Emerging Microbes & Infections·Sophie van TolChantal Reusken
Jun 28, 2020·Journal of Virology·John P Moore, P J Klasse
Sep 11, 2020·Nature Microbiology·Wen Shi LeeBrandon J DeKosky
Jul 22, 2020·Journal of Medical Virology·Yunfei WangCunbao Liu
Oct 13, 2020·Frontiers in Microbiology·Yuki Furuse, Hitoshi Oshitani
Oct 15, 2020·Signal Transduction and Targeted Therapy·Yetian DongFangfang Zhou
Sep 8, 2020·Clinical Chemistry·Mei San TangChristopher W Farnsworth
Oct 13, 2020·Nature·Christopher O BarnesPamela J Bjorkman
Sep 30, 2020·The Journal of Clinical Investigation·Massimiliano SecchiVito Lampasona
Oct 29, 2020·ELife·Yiska WeisblumPaul D Bieniasz
Nov 25, 2020·Current Opinion in HIV and AIDS·Pilar MendozaChristian Gaebler
Dec 9, 2020·Science Translational Medicine·Zijun WangMichel C Nussenzweig
Dec 16, 2020·SLAS Discovery·Dawid MaciorowskiAdinarayana Kunamneni
Dec 30, 2020·Klinicheskaia laboratornaia diagnostika·Boris Georgievich Andryukov, I N Lyapun
Nov 26, 2020·Computational and Structural Biotechnology Journal·Desh Deepak SinghDharmendra Kumar Yadav
Jan 14, 2021·Journal of Biomedical Science·Ioannis P TrougakosMeletios A Dimopoulos
Dec 12, 2020·Cell Host & Microbe·Drew WeissmanDavid C Montefiori

❮ Previous
Next ❯

Methods Mentioned

enzyme-linked immunosorbent assay
flow cytometry
biolayer interferometry
electron microscopy

Related Concepts

Related Feeds